Santen Pharmaceutical Co., Ltd. (SNPHY)
10.55
-0.57
(-5.13%)
USD |
OTCM |
Oct 02, 16:00
Santen Pharmaceutical Market Cap : 3.389B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.389B |
| October 01, 2026 | 3.572B |
| September 30, 2026 | 3.483B |
| September 29, 2026 | 3.387B |
| September 28, 2026 | 3.499B |
| September 25, 2026 | 3.549B |
| September 24, 2026 | 3.453B |
| September 23, 2026 | 3.488B |
| September 22, 2026 | 3.536B |
| September 21, 2026 | 3.514B |
| September 18, 2026 | 3.562B |
| September 17, 2026 | 3.674B |
| September 16, 2026 | 3.437B |
| September 15, 2026 | 3.588B |
| September 14, 2026 | 3.593B |
| September 11, 2026 | 3.620B |
| September 10, 2026 | 3.507B |
| September 09, 2026 | 3.750B |
| September 08, 2026 | 3.694B |
| September 04, 2026 | 3.768B |
| September 03, 2026 | 3.838B |
| September 02, 2026 | 3.607B |
| September 01, 2026 | 3.709B |
| August 31, 2026 | 3.857B |
| August 28, 2026 | 3.806B |
| Date | Value |
|---|---|
| August 27, 2026 | 3.752B |
| August 26, 2026 | 3.938B |
| August 25, 2026 | 3.782B |
| August 24, 2026 | 3.784B |
| August 21, 2026 | 3.806B |
| August 20, 2026 | 3.981B |
| August 19, 2026 | 3.832B |
| August 18, 2026 | 3.875B |
| August 17, 2026 | 3.986B |
| August 14, 2026 | 3.864B |
| August 13, 2026 | 3.911B |
| August 12, 2026 | 3.970B |
| August 11, 2026 | 3.988B |
| August 10, 2026 | 3.947B |
| August 07, 2026 | 3.780B |
| August 06, 2026 | 4.044B |
| August 05, 2026 | 3.925B |
| August 04, 2026 | 3.740B |
| August 03, 2026 | 3.664B |
| July 31, 2026 | 3.804B |
| July 30, 2026 | 3.799B |
| July 29, 2026 | 3.831B |
| July 28, 2026 | 3.849B |
| July 27, 2026 | 3.860B |
| July 24, 2026 | 3.748B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 56.45B |
| Daiichi Sankyo Co., Ltd. | 31.64B |
| Eisai Co., Ltd. | 8.417B |
| Chugai Pharmaceutical Co., Ltd. | 62.78B |
| Ono Pharmaceutical Co., Ltd. | 6.765B |
Market Cap Related Metrics
| PE Ratio | 13.74 |
| PS Ratio | 1.842 |
| PEG Ratio | 0.5286 |
| Price to Book Value | 1.834 |
| Price | 10.55 |
| Earnings Yield | 7.28% |
| PEGY Ratio | 0.5286 |
| Operating PE Ratio | 11.75 |